Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.0K
6.0K
Cancer02:18

Cancer

55.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.8K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

7.2K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.2K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

3.1K
3.1K
Cancer Prevention02:59

Cancer Prevention

8.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

The effect of gender on nephrectomy perioperative outcomes: a national survey.

The Canadian journal of urology·2012
Same author

Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: comparison over the three decades.

International journal of urology : official journal of the Japanese Urological Association·2012
Same author

Diagnosis and treatment of bladder endometriosis: state of the art.

Urologia internationalis·2012
Same author

Prostate saturation biopsy following a first negative biopsy: state of the art.

Urologia internationalis·2012
Same author

Effects of once-daily tadalafil on treatment satisfaction, psychosocial outcomes, spontaneous erections, and measures of endothelial function in men with erectile dysfunction but naive to phosphodiesterase type 5 inhibitors.

Journal of andrology·2012
Same author

Comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia: long-term results from the combination of dutasteride and tamsulosin study.

International journal of urology : official journal of the Japanese Urological Association·2012
Same journal

Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

Lancet (London, England)·2026
Same journal

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Lancet (London, England)·2026
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: Apr 4, 2026

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

799

腎臓がん

Umberto Capitanio1, Francesco Montorsi2

  • 1Department of Urology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Lancet (London, England)
|August 31, 2015
PubMed
まとめ
この要約は機械生成です。

腎臓細胞癌 (RCC) の診断と治療は急速に進化し,生存率が向上しています. 進歩には積極的な監視,最小侵襲的手術,標的治療が含まれていますが,進行した疾患では課題が残っています.

さらに関連する動画

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Published on: April 29, 2014

17.3K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.4K

関連する実験動画

Last Updated: Apr 4, 2026

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

799
Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Published on: April 29, 2014

17.3K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.4K

科学分野:

  • 腫瘍学
  • 泌尿器科

背景:

  • 腎臓細胞癌 (RCC) の発生率は上昇していますが,生存率は著しく改善しています.
  • 小規模で不活性なRCCの偶発的な診断は一般的です.
  • 局所的に進行した疾患や転移性疾患は依然として大きな課題です

研究 の 目的:

  • 腎臓細胞がんの診断と治療における最近の進歩をレビューする.
  • 局所性および進行性RCCの治療戦略の進化を強調する.
  • RCCケアにおける現在の不確実性と将来の研究方向性を特定する.

主な方法:

  • 最近の臨床試験とガイドラインのレビュー
  • RCCの診断と治療方法の動向の分析
  • 手術技術,監視,全身治療に関するデータの統合

主要な成果:

  • 活発な監視と腎臓を節約する外科技術 (例えば,ロボットによる手術) の採用を拡大する.
  • 小さな腫瘍の 熱処理のような 侵襲的処置の普及です
  • 手術と標的型生物学的薬剤を組み合わせた統合された戦略により,高度なRCCの治療結果を改善します.

結論:

  • RCCの管理における顕著な進歩は,特に初期段階での生存率の向上につながりました.
  • 手術による脱毛と標的型全身治療を組み合わせた統合されたアプローチは,進行したRCCの治療を改善します.
  • 進行中の研究は,残っている課題に対処し,腎臓細胞癌の患者のアウトカムをさらに改善するために不可欠です.